• Latest Posts
In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

In Depth 11 Oct 2023

Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19

In Depth 9 Oct 2023

The biggest private biotech investments in September 2023

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?  

In Depth 5 Oct 2023

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

In Depth 14 Sep 2023

Righting wrongs: genetic justice for Henrietta Lacks